Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2024-02-02 00:00:00 ET · period of report 2024-01-31 · accession 0000914475-24-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-02 | 2024-01-31+ | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale | $140.65 | -1,045 | 6,865 | -13% | -$147.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-31 | S | D | 422 | $141.94 | 6,309 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-01 | S | D | 623 | $139.77 | 6,865 | D | — | — |